Unlisted
| Company Name | (주)지놈앤컴퍼니 |
| English Name | Genome&Company |
| Business Reg. No. | 6278700257 |
| CEO | 홍유석, 배지수, 박한수 (각자 대표이사) |
| Address | 경기도 수원시 영통구 창룡대로256번길 50 7층, 8층 |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 211 |
| Main Products | 마이크로바이옴 기반 치료제, 화장품, 건강기능식품 제조,도소매,전자상거래 |
| Established | 20150924 |
| Phone | 031-628-0150 |
| Website | genomecom.co.kr |
| Regular Employees | 98persons |
| Corp. Reg. No. | 1341110422240 |
Venture Certified
| 기술평가보증기업(기금) | 2016-01-26 ~ 2018-01-25 | 20160100518 | 2016-01-26 |
| 연구개발유형 | 2018-01-26 ~ 2020-01-25 | 20180100717 | 2016-01-26 |
| 연구개발유형 | 2020-01-26 ~ 2022-01-25 | 20200105437 | 2016-01-26 |
| 연구개발유형 | 2022-01-26 ~ 2025-01-25 | 20220210020009 | 2016-01-26 |
| 연구개발유형 | 2025-01-26 ~ 2028-01-25 | 20250122020003 | 2016-01-26 |
Revenue CAGR +294.7%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 277B | 143B | 141B | 4.5B |
| Operating Profit | -242B | -551B | -575B | -361B |
| Net Profit | -268B | -507B | -569B | -360B |
| Total Assets | 1,473B | 1,621B | 1,730B | 1,372B |
| Total Liabilities | 483B | 485B | 225B | 238B |
| Total Equity | 991B | 1,135B | 1,505B | 1,134B |
Operating Loss: Op. profit -242B
4 Consecutive Years of Net Loss
▲ 188.7%
▲ 51.2%
▲ 97.0%
▲ 85.8%
▲ 28.8%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 배지수 | 사내이사 | 경영총괄 | - |
| 박병규 | 미등기 | 커뮤니케이션 담당 | - |
| 유현경 | 미등기 | 신약연구개발 | - |
| 서진경 | 미등기 | 컨슈머(화장품) | - |
| 박한수 | 사내이사 | 연구총괄 | - |
| 홍유석 | 사내이사 | 경영총괄 | - |
| 김상균 | 기타비상무이사 | 자문위원 | - |
| 정세현 | 사외이사 | 감사위원 | - |
| 이규연 | 사외이사 | 감사위원 | - |
| 박재연 | 사외이사 | 감사위원 | - |
| 차미영 | 미등기 | 신약 연구개발 | - |
| 정재욱 | 미등기 | 전략기획 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 98persons |
| CEO | 홍유석, 배지수, 박한수 (각자 대표이사) |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기 수원시",
"ceo_name": "배지수, 홍유석, 박한수",
"certificate": [
{
"cert_number": "20160100518",
"changes": "",
"disclosure_date": "2016-01-26",
"first_cert_date": "2016-01-26",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-01-26 ~ 2018-01-25"
},
{
"cert_number": "20180100717",
"changes": "",
"disclosure_date": "2018-01-26",
"first_cert_date": "2016-01-26",
"no": "2",
"type": "연구개발유형",
"valid_period": "2018-01-26 ~ 2020-01-25"
},
{
"cert_number": "20200105437",
"changes": "",
"disclosure_date": "2020-04-28",
"first_cert_date": "2016-01-26",
"no": "3",
"type": "연구개발유형",
"valid_period": "2020-01-26 ~ 2022-01-25"
},
{
"cert_number": "20220210020009",
"changes": "",
"disclosure_date": "2022-02-10",
"first_cert_date": "2016-01-26",
"no": "4",
"type": "연구개발유형",
"valid_period": "2022-01-26 ~ 2025-01-25"
},
{
"cert_number": "20250122020003",
"changes": "",
"disclosure_date": "2025-01-22",
"first_cert_date": "2016-01-26",
"no": "5",
"type": "연구개발유형",
"valid_period": "2025-01-26 ~ 2028-01-25"
}
],
"company_name": "주식회사 지놈앤컴퍼니",
"corp_no": "134111-*******",
"financials": {
"2022": {
"capital_stock": 7981721000,
"cost_of_sales": 1197616000,
"current_assets": 40321421000,
"current_liabilities": 5406094000,
"gross_profit": 757468000,
"net_income": -45214057000,
"net_income_bs": -45214056000,
"non_current_assets": 54430621000,
"non_current_liabilities": 849717000,
"non_operating_expenses": 1562153000,
"non_operating_income": 858804000,
"operating_profit": -44510708000,
"revenue": 1955084000,
"sga_expenses": 45268176000,
"total_assets": 94752042000,
"total_equity": 88496231000,
"total_liabilities": 6255811000
},
"2023": {
"capital_stock": 8082452000,
"cost_of_sales": 979443000,
"current_assets": 28389835000,
"current_liabilities": 24181313000,
"gross_profit": 1464365000,
"net_income": -47769140000,
"net_income_bs": -47769141000,
"non_current_assets": 58288580000,
"non_current_liabilities": 9743880000,
"non_operating_expenses": 12764029000,
"non_operating_income": 7374299000,
"operating_profit": -42379410000,
"revenue": 2443808000,
"sga_expenses": 43843775000,
"total_assets": 86678415000,
"total_equity": 52753222000,
"total_liabilities": 33925193000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [],
"main_products": "마이크로바이옴 기반 치료제, 화장품, 건강기능식품 제조,도소매,전자상거래",
"phone": "031-628-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |